The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform

Area of Science:

• Nanomedicine
• Biochemistry
• Oncology

Background:

• Dendrimer-based nanotherapeutics utilize folate molecules for cancer cell targeting.
• Previous studies inferred multivalent interactions but lacked experimental proof.

Purpose of the Study:

• To provide quantitative evidence of multivalent interactions between folate-dendrimer nanodevices and folate-binding protein (FBP).
• To elucidate the mechanism behind the enhanced biological targeting efficacy of these nanotherapeutics.

Main Methods:

• Synthesis of dendrimer-based nanodevices with varying folate conjugation densities.
• Surface Plasmon Resonance (SPR) to measure dissociation constants (K(D)) between nanodevices and FBP.
• Flow cytometry to assess multivalent targeting effects on KB cancer cells.

Main Results:

• SPR measurements revealed a dramatic enhancement in binding affinity (2,500- to 170,000-fold increase in K(D)) due to multivalency.
• Qualitative evidence confirmed multivalent targeting effects on KB cells.
• The study demonstrated that enhanced binding affinity, not increased endocytosis, drives improved targeting.

Conclusions:

• Multivalency significantly enhances the binding affinity of folate-dendrimer nanotherapeutics to FBP.
• The primary mechanism for improved biological targeting is the multivalent enhancement of dissociation constants.
• These findings support the use of multivalent strategies in designing effective anticancer nanodrug delivery systems.